The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial ...
The recent run of good fortune for vaccine maker Novavax (NASDAQ:NVAX continues. Following the major licensing deal with ...
Novavax (NVAX) stock surged after reaching a licensing agreement with Sanofi (SNY) for its COVID-19 vaccine and Matrix-M adjuvant. Read more here.
A Novavax shareholder that had been waging a campaign to oust three board members at the Gaithersburg company has now ...
By Ben Glickman Shares of Novavax continued their ascent on Monday, adding to gains from last week after the company announced a licensing deal with ...
Shah Capital Management has withdrawn a proxy campaign against the re-election of directors at vaccines firm Novavax in the ...
Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has ...
The vaccine maker's recovery story is looking brighter.
Novavax ( NVAX -9.65%) has been a highly volatile stock in recent years, and that volatility is on full display again this ...
Aventis S.A. ADR (SNY-Q) from The Globe and Mail including charting and trades.
The COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller ...
Novavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19-influenza combination ...